Facilitating drug discovery against COVID-19
A collaboration between EMBL Grenoble and EBRIS scientists led to the characterisation of a new compound with promising activity against SARS-CoV-2 variants.
EditA collaboration between EMBL Grenoble and EBRIS scientists led to the characterisation of a new compound with promising activity against SARS-CoV-2 variants.
EditSComatic enables researchers to link genotype to phenotype using only single-cell profiling data
EditThrough the collaborative framework agreement, EMBL and ZEISS aim to accelerate the development of imaging technology to advance life science research.
Edit